These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30025081)

  • 1. A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis.
    Kumaran N; Rubin GS; Kalitzeos A; Fujinami K; Bainbridge JWB; Weleber RG; Michaelides M
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3330-3339. PubMed ID: 30025081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results at 2 Years after Gene Therapy for RPE65-Deficient Leber Congenital Amaurosis and Severe Early-Childhood-Onset Retinal Dystrophy.
    Weleber RG; Pennesi ME; Wilson DJ; Kaushal S; Erker LR; Jensen L; McBride MT; Flotte TR; Humphries M; Calcedo R; Hauswirth WW; Chulay JD; Stout JT
    Ophthalmology; 2016 Jul; 123(7):1606-20. PubMed ID: 27102010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervisit variability of visual parameters in Leber congenital amaurosis caused by RPE65 mutations.
    Roman AJ; Cideciyan AV; Schwartz SB; Olivares MB; Heon E; Jacobson SG
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1378-83. PubMed ID: 23341016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results at 5 Years After Gene Therapy for RPE65-Deficient Retinal Dystrophy.
    Pennesi ME; Weleber RG; Yang P; Whitebirch C; Thean B; Flotte TR; Humphries M; Chegarnov E; Beasley KN; Stout JT; Chulay JD
    Hum Gene Ther; 2018 Dec; 29(12):1428-1437. PubMed ID: 29869534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.
    Jacobson SG; Cideciyan AV; Ratnakaram R; Heon E; Schwartz SB; Roman AJ; Peden MC; Aleman TS; Boye SL; Sumaroka A; Conlon TJ; Calcedo R; Pang JJ; Erger KE; Olivares MB; Mullins CL; Swider M; Kaushal S; Feuer WJ; Iannaccone A; Fishman GA; Stone EM; Byrne BJ; Hauswirth WW
    Arch Ophthalmol; 2012 Jan; 130(1):9-24. PubMed ID: 21911650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.
    Cideciyan AV; Jacobson SG; Beltran WA; Sumaroka A; Swider M; Iwabe S; Roman AJ; Olivares MB; Schwartz SB; Komáromy AM; Hauswirth WW; Aguirre GD
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):E517-25. PubMed ID: 23341635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy.
    Glen WB; Peterseim MMW; Badilla R; Znoyko I; Bourg A; Wilson R; Hardiman G; Wolff D; Martinez J
    Ophthalmic Genet; 2019 Apr; 40(2):110-117. PubMed ID: 30870047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
    Li S; Samardzija M; Yang Z; Grimm C; Jin M
    J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Parameswarappa DC; Bagga DK; Upadhyaya A; Balasubramanian J; Pochaboina V; Muthineni V; Jalali S; Kannabiran C
    Ophthalmic Genet; 2024 Jun; 45(3):303-312. PubMed ID: 38323530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.
    Weleber RG; Michaelides M; Trzupek KM; Stover NB; Stone EM
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):292-302. PubMed ID: 20811047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.
    Koenekoop RK; Sui R; Sallum J; van den Born LI; Ajlan R; Khan A; den Hollander AI; Cremers FP; Mendola JD; Bittner AK; Dagnelie G; Schuchard RA; Saperstein DA
    Lancet; 2014 Oct; 384(9953):1513-20. PubMed ID: 25030840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the residual vision in leber congenital amaurosis caused by RPE65 mutations.
    Jacobson SG; Aleman TS; Cideciyan AV; Roman AJ; Sumaroka A; Windsor EA; Schwartz SB; Heon E; Stone EM
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2368-75. PubMed ID: 19117922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal and cross-sectional study of patients with early-onset severe retinal dystrophy associated with RPE65 mutations.
    Paunescu K; Wabbels B; Preising MN; Lorenz B
    Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):417-26. PubMed ID: 15565294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients.
    Ashtari M; Nikonova ES; Marshall KA; Young GJ; Aravand P; Pan W; Ying GS; Willett AE; Mahmoudian M; Maguire AM; Bennett J
    Ophthalmology; 2017 Jun; 124(6):873-883. PubMed ID: 28237426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2.
    Testa F; Maguire AM; Rossi S; Pierce EA; Melillo P; Marshall K; Banfi S; Surace EM; Sun J; Acerra C; Wright JF; Wellman J; High KA; Auricchio A; Bennett J; Simonelli F
    Ophthalmology; 2013 Jun; 120(6):1283-91. PubMed ID: 23474247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Structure in RPE65-Associated Retinal Dystrophy.
    Kumaran N; Georgiou M; Bainbridge JWB; Bertelsen M; Larsen M; Blanco-Kelly F; Ayuso C; Tran HV; Munier FL; Kalitzeos A; Michaelides M
    Invest Ophthalmol Vis Sci; 2020 Apr; 61(4):47. PubMed ID: 32347917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity Reclasssification of
    Motta FL; Martin RP; Porto FBO; Wohler ES; Resende RG; Gomes CP; Pesquero JB; Sallum JMF
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31878136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa.
    Walia S; Fishman GA; Jacobson SG; Aleman TS; Koenekoop RK; Traboulsi EI; Weleber RG; Pennesi ME; Heon E; Drack A; Lam BL; Allikmets R; Stone EM
    Ophthalmology; 2010 Jun; 117(6):1190-8. PubMed ID: 20079931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature of the visual loss in observers with Leber's congenital amaurosis caused by specific mutations in RPE65.
    Ripamonti C; Henning GB; Ali RR; Bainbridge JW; Robbie SJ; Sundaram V; Luong VA; van den Born LI; Casteels I; de Ravel TJ; Moore AT; Stockman A
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6817-28. PubMed ID: 25257057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Loss of Tritan Color Discrimination in RPE65 Associated Leber Congenital Amaurosis.
    Kumaran N; Ripamonti C; Kalitzeos A; Rubin GS; Bainbridge JWB; Michaelides M
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):85-93. PubMed ID: 29332120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.